HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

Two arrested in investigation into serious assault in Leitrim

IMF claims Irish tax system is hurting the middle class

Two arrested in connection with alleged sexual assault in Dublin

Ryanair cuts cost of reserved seating for passengers travelling with children U12


Today's Stories

State asked for €500,000 each for six social housing apartments

Anger over Ryanair child fee for mandatory reserved seat

Christmas balloon’s flight brings Norwegian family to Cork

Kerry Group donates 2.3-acre Denny site to revitalise Tralee

Lifestyle

'Give Peas a Chance' competition involves raising food plants at your work desk

Eoin Colfer's new play looks at the pathos and humour of Multiple Sclerosis

Ask Audrey has been sorting out Cork people for years

POLL: Is Netflix damaging your sex life? Turn it off to get turned on

More From The Irish Examiner